The keynote panel, taking place at Genesis on 10 December at 1 Wimpole Street, London will explore the above question; What do you think should feature in the conversation? As the final preparations take shape, themes include:

• Perceived progress in unlocking domestic institutional capital (such as pension funds and insurance pools) to support later-stage (Series B and beyond) rounds, thus reducing the reliance on overseas venture capital that often forces early cross-border buyouts. 
• The potential for creative commercial structures such as co-development partnerships, regional licensing deals, and asset-swaps that provide non-dilutive or growth-stage funding.
• Can the domestic lab infrastructure, incubators, and science parks (e.g., Catapult networks, Cambridge/Oxford ecosystems) be leveraged more to scale operations cost-effectively.
• Do, and if not how can UK biotechs compete with US hubs (like Boston or San Francisco) for top-tier executive talent (such as seasoned CMOs and CFOs). 
• Developing pathways to train and retain cross-functional talent spanning clinical trial design, data science, and regulatory affairs.
• Maximising Unique UK Competitive Advantages, capitalising on world-class academic research institutions and unique health data assets (such as the UK Biobank and NHS datasets). 
• The Role of Government Policy and Regulation - Evaluating what fiscal incentives, tax credits (like R&D tax relief schemes), and pro-innovation regulatory frameworks the UK government must enact to make staying independent economically viable for founders and early investors.

Moderator – Rachel Bradley, Penningtons Manches Cooper
Panellists: Claire Skentelbery, EuropaBio, Hazel Jones, Laverock Therapeutics, Sheuli Porkess, PM Life Sciences Consultancy, George Freeman MP, Cora Griffin, Curve Therapeutics, Claire Cockerton, Kadans Science Partner

Help Shape the Conversation
Sharing your suggestions in advance will help shape the panel discussion. At Genesis, audience questions and networking conversations will further develop the key takeaways, provide an opportunity to showcase expertise and help build valuable connections.

Secure your place at Genesis.

Register for a Delegate pass (delegate rates from £325 + VAT) for access to all elements of the event.

Final Sponsorship and Exhibition Opportunities available, starting at £500+VAT.

Check out London Bio-innovation Week for additional opportunities to learn and meet the ecosystem. 

For more than 25 years, the Genesis Conference has provided that end-of-year opportunity to reflect on where we have been, where we are heading, and who we are going there with. It is a day not to be missed. 

Full details and registration options available on the Genesis website.